Evidence map›Paper›PMID 34043427›Full record

ReviewMolecular biology of the cell2021

Catalysts for change: the cellular neurobiology of psychedelics.

Matthew I Banks, Zarmeen Zahid, Nathan T Jones, Ziyad W Sultan, Cody J Wenthur

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular biology of the cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Towards an understanding of psychedelic-induced neuroplasticity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. The Hallucinogenic SerotoninFrontiers in molecular neuroscience · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew I BanksDepartment of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706.
Zarmeen ZahidNeuroscience Training Program, University of Wisconsin-Madison, Madison, WI 53706.
Nathan T JonesMolecular and Cellular Pharmacology Training Program, University of Wisconsin-Madison, Madison, WI 53706.
Ziyad W SultanDepartment of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706.
Cody J WenthurNeuroscience Training Program, University of Wisconsin-Madison, Madison, WI 53706.
University of Wisconsin–Madison · US

Funding

Training Program In Molecular AND Cellular PharmacologyT32GM008688 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 1998 to 2020
$6.0M
NIGMS NIH HHS T32 GM008688
6 · The paper itself

Abstract

The resurgence of interest in the therapeutic potential of psychedelics for treating psychiatric disorders has rekindled efforts to elucidate their mechanism of action. In this Perspective, we focus on the ability of psychedelics to promote

Indexed as

NeurobiologyHallucinogensHumansNeuronal PlasticityNeuronsSignal TransductionHallucinogens

Identifiers

PMID34043427
PMCPMC8351556
OpenAlexW3165796092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.